Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
The Korean Journal of Internal Medicine ; : 386-386, 2013.
Artículo en Inglés | WPRIM | ID: wpr-155774

RESUMEN

In the article, there were two spelling errors in the title and author affiliation.

2.
The Korean Journal of Internal Medicine ; : 165-173, 2013.
Artículo en Inglés | WPRIM | ID: wpr-117696

RESUMEN

BACKGROUND/AIMS: Acute coronary syndrome (ACS) is characterized by increased inflammatory processes and endothelial activation. We investigated the association between ACS and inflammatory mediators and matrix-degrading enzymes. METHODS: We prospectively enrolled 55 consecutive patients with ACS: 25 with unstable angina (UA) and 30 with non-ST elevated myocardial infarction (NSTEMI). For comparison, 25 age- and sex-matched subjects with no significant coronary artery stenosis were included as the control group. Peripheral serum levels of interleukin (IL)-33, matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP-1, and C-reactive protein (CRP) were measured on admission, and at 12, 24, 48, and 72 hours after the initial evaluation. RESULTS: Compared to serum levels in the control group, serum levels of IL-33 decreased in the NSTEMI group (p < 0.05), and levels of MMP-9 and tissue inhibitor of matrix metalloproteinase (TIMP)-1 increased in the UA group (p < 0.01, p < 0.05, respectively) and NSTEMI group (p < 0.05, p < 0.05, respectively). IL-33 levels were significantly lower on admission than at 12 hours after the initial evaluation (p < 0.05). IL-33 levels were negatively correlated with MMP-9 levels (r = -0.461, p < 0.05) and CRP levels (r = -0.441, p < 0.05). CONCLUSIONS: Elevated levels of MMP-9, TIMP-1, and decreased levels of IL-33 play a role in the development and progression of ACS.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Angina Inestable/sangre , Biomarcadores/sangre , Proteína C-Reactiva/metabolismo , Estudios de Casos y Controles , Progresión de la Enfermedad , Mediadores de Inflamación/sangre , Interleucinas/sangre , Metaloproteinasa 9 de la Matriz/sangre , Infarto del Miocardio/sangre , Factores de Tiempo , Inhibidor Tisular de Metaloproteinasa-1/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA